Verrica Pharmaceuticals Inc (VRCA) USD0.0001

Sell:$4.53Buy:$5.22No change

NASDAQ:0.00%
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.53
Buy:$5.22
Change:No change
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.53
Buy:$5.22
Change:No change
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 March 2025
Christopher G HayesChief Legal/Compliance Officer
Sell
Tax related
4,315$0.65$2,804.75176,458
22 November 2024
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
18,426,966$0.89$16,399,999.7426,278,094
22 November 2024
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
4,494,382$0.89$3,999,999.985,976,101
22 November 2024
Sean StalfortDirector
Buy
Regular purchase transaction
1,123,595$0.89$999,999.551,823,800
22 November 2024
Jayson RiegerPresident/CEO
Buy
Regular purchase transaction
280,898$0.89$249,999.22832,826

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 November 2024
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
18,426,966$0.89$16,399,999.7426,278,094
22 November 2024
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
4,494,382$0.89$3,999,999.985,976,101
22 November 2024
Sean StalfortDirector
Buy
Regular purchase transaction
1,123,595$0.89$999,999.551,823,800
22 November 2024
Jayson RiegerPresident/CEO
Buy
Regular purchase transaction
280,898$0.89$249,999.22832,826
17 March 2025
Christopher G HayesChief Legal/Compliance Officer
Sell
Tax related
4,315$0.65$2,804.75176,458

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.